Currently out of the existing stock ratings of Tycho Peterson, 133 are a BUY (63.94%), 49 are a HOLD (23.56%), 26 are a SELL (12.5%).

Tycho Peterson

Work Performance Price Targets & Ratings Chart

Analyst Tycho Peterson, currently employed at JEFFERIES, carries an average stock price target met ratio of 61.56% that have a potential upside of 17.32% achieved within 138 days. Previously, Tycho Peterson worked at JPMORGAN.

Tycho Peterson’s has documented 419 price targets and ratings displayed on 49 stocks. The coverage is on Basic Materials, Healthcare sectors.

Most recent stock forecast was given on ICLR, ICON PLC at 23-Feb-2026.

Wall Street Analyst Tycho Peterson

Analyst best performing recommendations are on ZY (ZYMERGEN).
The best stock recommendation documented was for ZY (ZYMERGEN) at 8/4/2021. The price target of $12 was fulfilled within 1 day with a profit of $3.75 (45.45%) receiving and performance score of 454.55.

Average potential price target upside

of $61.18 (18.81%) on TMO (THERMO FISHER SCIENTIFIC).
of $53.24 (19.99%) on ICLR (ICON PLC).
of $51.1 (26.14%) on LH (LABORATORY OF AMERICA HOLDINGS).

AVTR Avantor BLI Berkeley Lights CTLT Catalent ISRG Intuitive Surgical OCDX Ortho Clinical Diagnostics Holdings plc QDEL Quidel TLIS Talis Biomedical Corp TMO Thermo Fisher Scientific ZY Zymergen NSTG NanoString Technologies NTRA Natera NVST Envista Holdings Corp PPD PPD TX Ternium SA ADR A Agilent Technologies BRKR Bruker CRL Charles River Laboratories DHR Danaher GH Guardant Health ICLR ICON PLC ILMN Illumina IQV IQVIA Holdings MYGN Myriad Genetics OMIC Singular Genomics Systems SHC Sotera Health Co RPID Rapid Micro Biosystems SEER Seer SYNH Syneos Health TWST Twist Bioscience Corp XRAY Dentsply Sirona QTRX Quanterix Corp RGEN Repligen RNLX Renalytix AI ABSI Absci Corp AKYA Akoya Biosciences QGEN Qiagen NV WAT Waters LH Laboratory of America Holdings MTD Mettler-Toledo International OSUR OraSure Technologies GNMK GenMark Diagnostics HOLX Hologic LMNX Luminex PACB Pacific Biosciences of California TXG 10X Genomics ADPT Adaptive Biotechnologies Corp GHDX Genomic Health NEO NeoGenomics DGX Quest Diagnostics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Luke Sergott (BARCLAYS)